Prevas: Should continue to perform in Q3 - ABG
6% organic growth expected in Q3
We are a bit more cautious long-term
Report due 26 October
Q3e: Sales +14% y-o-y and EBITA margin of 11% (11.7%)
>Prevas is set to report its Q3 numbers on 26 October and we expect a solid report, with 6% organic sales growth and a slightly lower EBITA margin y-o-y, driven by a negative calendar effect with one less working day in Q3 compared to last year. Underlying market conditions for technological consultants have remained solid in Q3 despite weaker service PMIs in Sweden, and we deem Prevas' end-market exposure to be beneficial, with roughly 60% of sales coming from Engineering, Life Science, Energy and Defence. Our understanding is that demand is still holding up in these end-markets.
Länk till analysen i sin helhet: https://cr.abgsc.com/foretag/prevas/Equity-research/2023/10/prevas---should-continue-to-perform-in-q3/